Publication: nature.com | Publication Date: November 23, 2017

Authors: Theodora Panagaki, Maria Michael & Christian Hölscher

Abstract

Growing evidence suggests that agonists of glucagon-like peptide (GLP-1) receptor exert neuroprotective and neurorestorative effects across a range of experimental models of neuronal degeneration, and, recently, a pilot clinical trial of Liraglutide in Alzheimer’s disease patients showed improvements in cerebral glucose consumption that signifies disease progression. Read more

Tim Barrett update for Winter TreatWolfram newsletter

Dear friends and colleagues,

I hope everyone is keeping OK and are keeping warm enough in this cold weather. Our research teams have kept busy and I would like to use this letter to keep you updated on our progress.

The TREATWOLFRAM trial is now in its final year. It has been a long journey to get here, navigating medicine manufacture problems, BREXIT, Covid, and supply issues. Thank you to all the participants who have supported the trial with their involvement. Our trials unit team, Amy Lamb, Lewis James Victoria Homer and Darren Barton, are working hard to make sure all the information that participants have kindly supplied, will be ready to be analysed when the trial ends in October 2024. There has been an update from the UK Medicines Regulator (MHRA) to remind patients and the public about the safety precautions we all need to follow for people taking sodium valproate. Anyone female under 55 years who may be taking sodium valproate, needs to have a safety check with their doctor each year. It is important that sodium valproate should not be taken by women who may be pregnant, as there is a risk of significant harm to the baby. There is helpful information on this UK Government website: https://www.gov.uk/guidance/valproate-use-by-women-and-girls.

Read more

Our mission to create a world without Wolfram syndrome. Our goal is to raise $25,000 this year. We need your help to get us there. Help us Spread the word about our campaign and reach our $25,000 goal http://thesnowfoundation.org/donate/  

One week left to Giving Tuesday. Let’s make a Historic day of giving for The Snow Foundation. Spread the word, gather colleagues, friends and family to donate. http://thesnowfoundation.org/donate/

“I have found that among its other benefits, giving liberates the soul of the giver.” Maya Angelou 

Spread the word and help us reach our goal of $25,000, start a campaign for The Snow Foundation http://thesnowfoundation.org/donate/  

Share our Giving Tuesday campaign with your family and friends. Invite them to join the cause, too. Let’s find a CURE. givingtuesday #wolframsyndrome, http://thesnowfoundation.org/donate/ 

Giving Tuesday is a global movement that falls on the Tuesday after Thanksgiving every year, please help us reach our goal of $25,000 on November 28thth http://thesnowfoundation.org/donate/

How to care for your eyes when you have diabetes:

https://www.parkview.com/blog/how-to-care-for-your-eyes-when-you-have-diabetes

CRISPR-based genome editing restores the vision of mice with retinitis pigmentosa

https://www.news-medical.net/news/20230317/CRISPR-based-genome-editing-restores-the-vision-of-mice-with-retinitis-pigmentosa.aspx